
Sensitive Bone Marrow Test Could Double Long-Term Survival Rates for Some Acute Myeloid Leukemia Patients
A groundbreaking advancement in the monitoring of Acute Myeloid Leukaemia (AML) has emerged from recent clinical trials led by King’s College London, introducing a highly sensitive bone marrow molecular test that could significantly elevate survival rates …